Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models-Reference-Cited by-同舟云学术

Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models

Published:2017-09 Issue:9 Volume:106 Page:2739-2750
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Yoshikado Takashi,Maeda Kazuya,Kusuhara Hiroyuki,Furihata Ken-ichi,Sugiyama Yuichi

Funder

Grant-in-Aid for Scientific Research

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans;Watanabe;J Pharmacokinet Pharmacodyn,2010

2. Quantitative analyses of hepatic OATP-mediated interactions between statins and inhibitors using PBPK modeling with a parameter optimization method;Yoshikado;Clin Pharmacol Ther,2016

3. Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study;Maeda;Clin Pharmacol Ther,2011

4. A clinical cassette dosing study for evaluating the contribution of hepatic OATPs and CYP3A to drug-drug interactions;Yoshikado;Pharm Res,2017

5. Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1;Higgins;Drug Metab Dispos,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically‐based pharmacokinetic modeling for investigating the effect of simeprevir on concomitant drugs and an endogenous biomarker of OATP1B;CPT: Pharmacometrics & Systems Pharmacology;2023-09-04

2. Development of Prediction Methods for Drug–Drug Interactions Based on the Construction of Physiologically Based Pharmacokinetic Models for Hepatic OATP Substrate Drugs and Endogenous Substrates;YAKUGAKU ZASSHI;2023-01-01

3. IN VITRO–IN VIVOSCALE‐UP OF DRUG TRANSPORT ACTIVITIES;Drug Transporters;2022-04-05

4. Physiologically-based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-drug Interactions;Current Drug Metabolism;2021-09-14

5. Application of a PBPK Model Incorporating the Interplay Between Transporters and Drug‐Metabolizing Enzymes for the Precise Prediction of Drug Toxicity;Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity;2021-07-02